Skip to content
Screener

Innoviva, Inc. INVA Net Change in Cash

Net Change in Cash at other companies

Pfizer logo
PfizerPFE
$563M+50.1%
Merck & Co. logo
Merck & Co.MRK
-$9.29B-103%
AbbVie logo
AbbVieABBV
$4.16B+1,293%
Insmed logo
InsmedINSM
$71.74M+147%
Savara logo
SavaraSVRA
$3.01M
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$16.56M+168%

Other financials

Income statement

See full
Revenue$119.6M+19.3%
Gross profit$90.6M+9.0%
Operating income$50.9M+4.3%
Net income-$83.4M-231%
EPS (diluted)-$1.14-248%

Balance sheet

See full
Cash & equivalents$570.4M+43.5%
Total debt$269.7M-40.2%
Total equity$1.2B
Total assets$1.7B+27.7%

Cash flow

See full
Operating cash flow$52.0M+17.9%
CapEx$429.0K
Free cash flow$51.5M+16.9%

Valuation

See full
Market cap$1.49B+20.6%
Enterprise value$1.19B-7.6%
P/E4.2×-27.8×
P/S3.4×+0.1×

Profitability

See full
Gross margin72.2%-10.9pp
Operating margin36.9%-10.7pp
Net margin81.2%+70.8pp
FCF margin43.1%-11.1pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio16×+13.4×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: Innoviva, Inc.’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:29 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-209110
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Cash flows from financing activities
Repurchase of common stock(20,247)
Repurchase of shares to satisfy tax withholding(158)(67)
Proceeds from issuances of common stock, net259250
Net cash provided by (used in) financing activities(20,146)183
Net increase in cash and cash equivalents52,14414,126
Cash and cash equivalents at beginning of period550,941304,964
Cash and cash equivalents at end of period$603,085$319,090

Item 1. Financial Statements

FAQ

What is Innoviva, Inc.'s net change in cash?
Innoviva, Inc. (INVA) reported net change in cash of $52.14M in Q1 2026.
How has Innoviva, Inc.'s net change in cash changed year-over-year?
Innoviva, Inc.'s net change in cash increased by 269.1% year-over-year, from $14.13M to $52.14M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about Innoviva, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude